Is Cefepime Hydrochloride Injection in shortage?
Cefepime Hydrochloride Injection is listed by FDA as being discontinued by at least one maker (updated Feb 10, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20)
Discontinuation of the manufacture of the drug.
Maker contact: 888-386-1300
- Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20)
Discontinuation of the manufacture of the drug.
Maker contact: 888-386-1300
FDA recalls of Cefepime Hydrochloride
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Cefepime Hydrochloride Injection:
Cefepime Hydrochloride Injection shortage questions
Is Cefepime Hydrochloride Injection in shortage?
Cefepime Hydrochloride Injection is listed by FDA as being discontinued by at least one maker (updated Feb 10, 2026).
What should I do if I can’t get Cefepime Hydrochloride Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.